Alternative Endpoints and Models for AD Prevention Trials von Wang, Guoqiao, Li, Yan, Xiong, Chengjie, McDade, Eric, Bateman, Randall J.

Volltext

Evaluation of the performance of alternative models in analyzing longitudinal data for Alzheimer clinical trials compared to MMRM von Wang, Guoqiao, Li, Yan, Xiong, Chengjie, Liu, Lei, Kennedy, Richard E, Schneider, Lon S., Natanegara, Fanni, McDade, Eric, Bateman, Randall J.

Volltext

Relative efficiency of equal versus unequal cluster sizes in cluster randomized trials with a small number of clusters von Liu, Jingxia, Xiong, Chengjie, Liu, Lei, Wang, Guoqiao, Jingqin, Luo, Gao, Feng, Chen, Ling, Li, Yan

Volltext

Estimating diagnostic accuracy for clustered ordinal diagnostic groups in the three-class case—Application to the early diagnosis of Alzheimer disease von Xiong, Chengjie, Luo, Jingqin, Chen, Ling, Gao, Feng, Liu, Jingxia, Wang, Guoqiao, Bateman, Randall, Morris, John C

Volltext

Staging Biomarkers in Preclinical Autosomal Dominant Alzheimer Disease by Estimated Years to Symptom Onset von Wang, Guoqiao, Coble, Dean, McDade, Eric M., Hassenstab, Jason, Fagan, Anne M., Benzinger, Tammie L.S., Bateman, Randall J., Morris, John C., Xiong, Chengjie

Volltext

O1‐09‐02: TWO‐PERIOD LINEAR MIXED EFFECTS PRIMARY ANALYSIS MODEL FOR CLINICAL TRIALS WITH RUN‐IN DATA FOR ALZHEIMER DISEASE von Wang, Guoqiao, Aschenbrenner, Andrew J., Li, Yan, Mcdade, Eric, Liu, Lei, Benzinger, Tammie L.S., Bateman, Randall, Morris, John C., Hassenstab, Jason, Berry, Scott, Xiong, Chengjie

Volltext

TWO-PERIOD LINEAR MIXED EFFECTS PRIMARY ANALYSIS MODEL FOR CLINICAL TRIALS WITH RUN-IN DATA FOR ALZHEIMER DISEASE von Wang, Guoqiao, Aschenbrenner, Andrew J., Li, Yan, Mcdade, Eric, Liu, Lei, Benzinger, Tammie L.S., Bateman, Randall, Morris, John C., Hassenstab, Jason, Berry, Scott, Xiong, Chengjie

Volltext

A NOVEL ALTERNATIVE MODEL TO MMRM AS THE PRIMARY MODEL FOR SPORADIC AD CLINICAL TRIALS: THE PROPORTIONAL MMRM von Wang, Guoqiao, Xiong, Chengjie, McDade, Eric, Li, Yan, Aschenbrenner, Andrew J., Hassenstab, Jason, Berry, Scott, Bateman, Randall J.

Volltext

P2‐076: A NOVEL ALTERNATIVE MODEL TO MMRM AS THE PRIMARY MODEL FOR SPORADIC AD CLINICAL TRIALS: THE PROPORTIONAL MMRM von Wang, Guoqiao, Xiong, Chengjie, McDade, Eric, Li, Yan, Aschenbrenner, Andrew J., Hassenstab, Jason, Berry, Scott, Bateman, Randall J.

Volltext

P1‐023: MASS SPECTROMETRY–BASED MEASUREMENT OF LONGITUDINAL CSF TAU IDENTIFIES DIFFERENT PHOSPHORYLATED SITES THAT TRACK DISTINCT STAGES OF PRESYMPTOMATIC DOMINANTLY INHERITED AD... von Barthélemy, Nicolas R., Li, Yan, Wang, Guoqiao, Fagan, Anne M., Morris, John C., Benzinger, Tammie L.S., Goate, Alison, Hassenstab, Jason, Xiong, Chengjie, Sato, Chihiro, Bateman, Randall J., McDade, Eric

Volltext

MASS SPECTROMETRY–BASED MEASUREMENT OF LONGITUDINAL CSF TAU IDENTIFIES DIFFERENT PHOSPHORYLATED SITES THAT TRACK DISTINCT STAGES OF PRESYMPTOMATIC DOMINANTLY INHERITED AD von Barthélemy, Nicolas R., Li, Yan, Wang, Guoqiao, Fagan, Anne M., Morris, John C., Benzinger, Tammie L.S., Goate, Alison, Hassenstab, Jason, Xiong, Chengjie, Sato, Chihiro, Bateman, Randall J., McDade, Eric

Volltext

F5‐02‐01: COGNITIVE TRAJECTORIES IN DIAN: RELATIONSHIPS WITH SYMPTOM ONSET, MUTATION TYPES, AND CLINICAL STATUS von Hassenstab, Jason, Aschenbrenner, Andrew J., Balota, David A., Lim, Yen Ying, McDade, Eric, Wang, Guoqiao, Xiong, Chengjie, Buckles, Virginia, Moulder, Krista L., Paumier, Katrina L., Bateman, Randall, Morris, John C.

Volltext

P4‐004: Planning Dose Escalation in Phase III Clinical Trials May Prevent Underpowered Trials and Mitigate the Increase in Sample Size or Duration of Adaptive Trials von Wang, Guoqiao, McDade, Eric, Bateman, Randall, Hassenstab, Jason, Farlow, Martin R., Salloway, Stephen, Kennedy, Richard E., Schneider, Lon S., Berry, Scott, Xiong, Chengjie

Volltext

O1‐09‐02: TWO‐PERIOD LINEAR MIXED EFFECTS PRIMARY ANALYSIS MODEL FOR CLINICAL TRIALS WITH RUN‐IN DATA FOR ALZHEIMER DISEASE von Wang, Guoqiao, Aschenbrenner, Andrew J., Li, Yan, Mcdade, Eric, Liu, Lei, Benzinger, Tammie L.S., Bateman, Randall, Morris, John C., Hassenstab, Jason, Berry, Scott, Xiong, Chengjie

Volltext

A STATISTICAL METHOD FOR DETERMINING BIOMARKER THRESHOLD FOR ALZHEIMER’S DISEASE von Li, Yan, Wang, Guoqiao, Xiong, Chengjie, McDade, Eric, Fagan, Anne M., Gordon, Brian A., Benzinger, Tammie L.S., Aschenbrenner, Andrew J., Hassenstab, Jason, Bateman, Randall J.

Volltext

P2‐072: A STATISTICAL METHOD FOR DETERMINING BIOMARKER THRESHOLD FOR ALZHEIMER'S DISEASE von Li, Yan, Wang, Guoqiao, Xiong, Chengjie, McDade, Eric, Fagan, Anne M., Gordon, Brian A., Benzinger, Tammie L.S., Aschenbrenner, Andrew J., Hassenstab, Jason, Bateman, Randall J.

Volltext

CROSS-SECTIONAL AND LONGITUDINAL RELATIONSHIPS AMONG BIOMARKERS FOR DOMINANTLY INHERITED ALZHEIMER’S DISEASE AND ITS COMPARISON WITH SPORADIC AD von Wang, Guoqiao, Xiong, Chengjie, McDade, Eric, Li, Yan, Aschenbrenner, Andrew J., Hassenstab, Jason, Fagan, Anne M., Gordon, Brian A., Benzinger, Tammie L.S., Morris, John C., Bateman, Randall J.

Volltext

P1‐119: CROSS‐SECTIONAL AND LONGITUDINAL RELATIONSHIPS AMONG BIOMARKERS FOR DOMINANTLY INHERITED ALZHEIMER'S DISEASE AND ITS COMPARISON WITH SPORADIC AD von Wang, Guoqiao, Xiong, Chengjie, McDade, Eric, Li, Yan, Aschenbrenner, Andrew J., Hassenstab, Jason, Fagan, Anne M., Gordon, Brian A., Benzinger, Tammie L.S., Morris, John C., Bateman, Randall J.

Volltext

Flat panel display processing method with environmental pollution prevention measures von SHI WENBIN, LIU LILI, XIONG GUOQIAO, LIU YONG

Volltext bestellen

QUANTIFYING PRECLINICAL STAGES OF AUTOSOMAL DOMINANT ALZHEIMER DISEASE (ADAD) AND THE ASSOCIATED OVERALL BIOMARKER SIGNATURE ACROSS MODALITIES USING THE DOMINANTLY INHERITED ALZHEI... von Xiong, Chengjie, Wang, Guoqiao, Coble, Dean, Fague, Scot, Fagan, Anne M., Benzinger, Tammie L.S., Hassenstab, Jason, Buckles, Virginia, Moulder, Krista L., Paumier, Katrina L., Morris, John C., Bateman, Randall J.

Volltext